Latest / Philadelphia News Today | 2 Min News | The Daily News Now!
FDA Panel Votes to Ease Peptide Restrictions | Philadelphia News
A controversial FDA advisory panel narrowly voted to loosen restrictions on popular but unproven injectable peptides like BPC-157 and TB-500, sparking debate over patient access versus scientific safety. With eight to six votes and one abstention, the panel—some members tied to the peptide industry—recommended easing rules, aligning with Health Secretary Robert F. Kennedy Jr.’s push to overturn current regulations. Critics warn of a dangerous, unregulated market lacking human studies and clear formulations, while supporters argue the move empowers patients and doctors. The final decision…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.